aluminum hydroxide 160 MG / magnesium carbonate 105 MG Chewable Tablet [Gaviscon]
RxNorm concept 212978, branded drug (sbd). Prescribable name: Gaviscon Extra Strength 160 MG / 105 MG Chewable Tablet.
- RxCUI
- 212978
- Term type
- Branded drug (SBD)
- Status
- Active
curl https://api.healthcare.dev/v1/drugs/rxnorm/212978 \ -H "Authorization: Bearer $HDEV_API_KEY"
Concept
Ingredients and related concepts
Ingredients
Other names
Gaviscon Extra Strength (aluminum hydroxide 160 MG / magnesium carbonate 105 MG) Chewable Tablet
Related concepts
- aluminum hydroxide 160 MG (SCDC, consists of)
- magnesium carbonate 105 MG (SCDC, consists of)
- aluminum hydroxide 160 MG / magnesium carbonate 105 MG [Gaviscon] (SBDC, consists of)
- Chewable Tablet (DF, has dose form)
- Gaviscon (BN, has ingredient)
- aluminum hydroxide 160 MG / magnesium carbonate 105 MG Chewable Tablet (SCD, tradename of)
Linked data
NDCs
- 00088117447
- 00135009826
- 00135043003
NDC-11s RxNorm links to this concept; linked ones open their FDA product.
Use it
Look up 212978 from code or an agent
curl https://api.healthcare.dev/v1/drugs/rxnorm/212978 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up RxNorm concept 212978. Tell me its name and term type, its ingredients and related concepts, and the NDCs linked to it.
Source: U.S. National Library of Medicine, release 2026-10-05. No license required (Current Prescribable Content). Reference data, not medical advice.